Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D O Calligaro

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Life Sciences|January 1, 1995
Muscarinic agonists as analgesics. Antinociceptive activity versus M1 activity: SAR of alkylthio-TZTP's and related 1,2,5-thiadiazole analogsP Sauerberg, P H Olesen, M J Sheardown, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1993
Preclinical studies on LY228729: a potent and selective serotonin1A agonistM M Foreman, R W Fuller, J D Leander, et al.
Life Sciences|January 1, 1997
Characterization of LY344864 as a pharmacological tool to study 5-HT1F receptors: binding affinities, brain penetration and activity in the neurogenic dural inflammation model of migraineL A Phebus, K W Johnson, J M Zgombick, et al.
Journal of Medicinal Chemistry|January 23, 1998
Conformationally constrained analogues of the muscarinic agonist 3-(4-(methylthio)-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyr idine. Synthesis, receptor affinity, and antinociceptive activityP Sauerberg, P H Olesen, M J Sheardown, et al.
Neuroreport|December 17, 1998
Muscarinic agonists exhibit functional dopamine antagonism in unilaterally 6-OHDA lesioned ratsA Fink-Jensen, P Kristensen, H E Shannon, et al.
Journal of Medicinal Chemistry|February 17, 1998
1,2,5-Thiadiazole analogues of aceclidine as potent m1 muscarinic agonistsJ S Ward, L Merritt, D O Calligaro, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 20, 1999
Muscarinic receptor agonists, like dopamine receptor antagonist antipsychotics, inhibit conditioned avoidance response in ratsH E Shannon, J C Hart, F P Bymaster, et al.
Schizophrenia Research|May 10, 2001
The muscarinic receptor agonist BuTAC, a novel potential antipsychotic, does not impair learning and memory in mouse passive avoidanceT Rasmussen, A Fink-Jensen, P Sauerberg, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1997
Butylthio[2.2.2] (NNC 11-1053/LY297802): an orally active muscarinic agonist analgesicM D Swedberg, M J Sheardown, P Sauerberg, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1994
Neurochemical effects of the M1 muscarinic agonist xanomeline (LY246708/NNC11-0232)F P Bymaster, D T Wong, C H Mitch, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Life Sciences|January 1, 1995
Muscarinic agonists as analgesics. Antinociceptive activity versus M1 activity: SAR of alkylthio-TZTP's and related 1,2,5-thiadiazole analogsP Sauerberg, P H Olesen, M J Sheardown, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1993
Preclinical studies on LY228729: a potent and selective serotonin1A agonistM M Foreman, R W Fuller, J D Leander, et al.
Life Sciences|January 1, 1997
Characterization of LY344864 as a pharmacological tool to study 5-HT1F receptors: binding affinities, brain penetration and activity in the neurogenic dural inflammation model of migraineL A Phebus, K W Johnson, J M Zgombick, et al.
Journal of Medicinal Chemistry|January 23, 1998
Conformationally constrained analogues of the muscarinic agonist 3-(4-(methylthio)-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyr idine. Synthesis, receptor affinity, and antinociceptive activityP Sauerberg, P H Olesen, M J Sheardown, et al.
Neuroreport|December 17, 1998
Muscarinic agonists exhibit functional dopamine antagonism in unilaterally 6-OHDA lesioned ratsA Fink-Jensen, P Kristensen, H E Shannon, et al.
Journal of Medicinal Chemistry|February 17, 1998
1,2,5-Thiadiazole analogues of aceclidine as potent m1 muscarinic agonistsJ S Ward, L Merritt, D O Calligaro, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 20, 1999
Muscarinic receptor agonists, like dopamine receptor antagonist antipsychotics, inhibit conditioned avoidance response in ratsH E Shannon, J C Hart, F P Bymaster, et al.
Schizophrenia Research|May 10, 2001
The muscarinic receptor agonist BuTAC, a novel potential antipsychotic, does not impair learning and memory in mouse passive avoidanceT Rasmussen, A Fink-Jensen, P Sauerberg, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1997
Butylthio[2.2.2] (NNC 11-1053/LY297802): an orally active muscarinic agonist analgesicM D Swedberg, M J Sheardown, P Sauerberg, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1994
Neurochemical effects of the M1 muscarinic agonist xanomeline (LY246708/NNC11-0232)F P Bymaster, D T Wong, C H Mitch, et al.
Pageof 5